載入...
Pembrolizumab in mycosis fungoides with PD-L1 structural variants
PD-L1 structural variants are recurrent in mycosis fungoides with large cell transformation. PD-L1 structural variants in relapsed/refractory mycosis fungoides should prompt consideration of treatment with PD-1 inhibitors.
Na minha lista:
| 發表在: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7876893/ https://ncbi.nlm.nih.gov/pubmed/33560388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002371 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|